Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Marrow fat |
Is a |
True |
Fat |
Inferred relationship |
Some |
|
Fat embolism |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Pulmonary fat embolism |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Subacute pulmonary fat embolism |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Fulminant fat embolism syndrome |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Fat embolism as early complication of trauma |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Fat embolism - obstetric |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
|
Fedttilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
kolintilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af mediumkædede triglycerider |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af langkædede triglycerider |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af mættet fedt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af enkeltumættede fedtstoffer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af flerumættede fedtstoffer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af flerumættede fedtsyrer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af n-3-fedtsyrer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af alfa-linolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af gamma-linolensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af arakidonsyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af n-6-fedtsyrer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af linolsyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af eicosapentaensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
tilskud bestående af docosahexaensyre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Intravenous nutrition (fats) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 10 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fat |
Inferred relationship |
Some |
|
Grafting of mediastinal fat to myocardium |
Using substance (attribute) |
False |
Fat |
Inferred relationship |
Some |
1 |
Intravenous nutrition (fats) adverse reaction (disorder) |
Causative agent |
True |
Fat |
Inferred relationship |
Some |
1 |
Fecal fat screening test |
Component |
False |
Fat |
Inferred relationship |
Some |
2 |
Autologous fat |
Is a |
True |
Fat |
Inferred relationship |
Some |
|
Lipofilling of breast |
Using substance (attribute) |
True |
Fat |
Inferred relationship |
Some |
1 |
Grafting of skin and fat to eyelid (procedure) |
Direct substance |
True |
Fat |
Inferred relationship |
Some |
2 |
Induced termination of pregnancy complicated by fat embolism (disorder) |
Causative agent |
True |
Fat |
Inferred relationship |
Some |
2 |
Legal abort med fedtemboli |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
1 |
Illegal abort med fedtemboli |
Causative agent |
False |
Fat |
Inferred relationship |
Some |
1 |
Fat absorption test |
Component |
True |
Fat |
Inferred relationship |
Some |
1 |
Fecal fat screening test |
Component |
True |
Fat |
Inferred relationship |
Some |
1 |
Grafting of mediastinal fat to myocardium |
Direct substance |
True |
Fat |
Inferred relationship |
Some |
1 |
Grafting of mediastinal fat to myocardium |
Direct substance |
True |
Fat |
Inferred relationship |
Some |
2 |